Protalix Biotherapeutics Inc (NYSE American:PLX)
| 3.55 Delayed Data As of Jan 17 |  -0.08 / -2.20%Today’s Change | 1.70 Today|||52-Week Range 6.00 | +8.23% Year-to-Date |
Latest PLX News | Press Releases
No recent news for Protalix Biotherapeutics Inc.
Today’s Trading
| Previous close | 3.63 |
| Today’s open | 3.55 |
| Day’s range | 3.47 - 3.63 |
| Volume | 62,016 |
| Average volume (3 months) | 132,507 |
| Market cap | $53.4M |
Data as of 8:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +72.34% |
| Earnings growth (this year) | +20.00% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +77.94% |
| P/E ratio | NM |
| Price/Sales | 1.34 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TORCresTORbio, Inc. | -0.04 | -2.67% |
| VBLTVascular Biogenics L... | +0.02 | +1.42% |
| ITRMIterum Therapeutics ... | -1.16 | -26.01% |
| AQBAquaBounty Technolog... | -0.19 | -7.61% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $34.2M |
| Annual profit (last year) | -$26.5M |
| Net profit margin | -77.27% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Carmiel, Hazafon |
Forecasts
